Big Pharma uses Big Tobacco's strategy to defeat Ivermectin
Justus R. Hope, MD
Apr 12, 2021 / Deseret News --
Today we know that the earlier Ivermectin is given, the lower the death rate. We learned in the 1950s that the more cigarettes one smoked, and the longer they smoked, the higher the death rate.
We now have 50 studies all showing Ivermectin's benefits across all stages of COVID-19, with The World Health Organization finding an average of 81% decreased mortality.
Merck and the FDA came out against Ivermectin only after the US government contributed $356-million to Merck to develop MK-7110, a [new] anti-COVID drug.
This occurred after Merck purchased the rights to MK-7110 for $425 million in a deal announced on December 23, 2020. The chances of this drug receiving approval by the FDA are very high.
The chances of Ivermectin successfully competing against MK-7110, if Ivermectin is also approved, are also high.
It is, therefore, logical that a multi-billion dollar industry will use its immense lobbying, media, and advertising power to prevent this.
The smoking gun here is that Merck was the original developer of Ivermectin, but now that their old drug is generic and no longer profitable, it is being tossed under the proverbial bus.
Obfuscation and the "offer-to-fund-the-research" through a time-honored and proven strategy of manipulation is once again proving remarkably effective in swaying public opinion.
We have seen this movie before with Big Tobacco.
We already know how it ends. We have 50 studies, all showing Ivermectin's life-saving benefits. We do not need 50 more to tell that Ivermectin prevents COVID death and should be adopted immediately. The science is clear based upon numerous meta-analyses already performed by world-class and respected scientists Dr. Tess Lawrie, Dr. Andrew Hill, and Dr. Pierre Kory.
This brings me to the Washington Post's April 8, 2021 article which announced that the government planned to do their own Ivermectin study. Thanks, but no thanks, to the NIH, in their magnanimous offer to conduct more "research." We already know what they will find.